Evommune Inc (EVMN)

Currency in USD
23.59
+0.26(+1.09%)
Real-time Data·
EVMN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.4524.11
52 wk Range
13.8933.20
Key Statistics
Prev. Close
23.33
Open
23.59
Day's Range
22.45-24.11
52 wk Range
13.89-33.2
Volume
118.4K
Average Volume (3m)
602.15K
1-Year Change
-
Book Value / Share
6.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVMN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
51.00
Upside
+116.19%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Evommune Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.

Compare EVMN to Peers and Sector

Metrics to compare
EVMN
Peers
Sector
Relationship
P/E Ratio
−12.5x−6.4x−0.5x
PEG Ratio
−0.17−0.200.00
Price/Book
4.2x0.0x2.6x
Price / LTM Sales
66.1x76.9x3.1x
Upside (Analyst Target)
110.6%70.9%57.5%
Fair Value Upside
Unlock−5.8%8.1%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 51.00
(+116.19% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy50.00+111.60%65.00MaintainMar 18, 2026
Clear Street
Buy53.00+124.29%-New CoverageMar 17, 2026
Leerink Partners
Buy52.00+120.06%-MaintainMar 12, 2026
RBC Capital
Buy48.00+103.13%-New CoverageMar 11, 2026
Morgan Stanley
Buy54.00+128.52%36.00MaintainFeb 19, 2026

Earnings

Latest Release
Mar 05, 2026
EPS / Forecast
-1.43 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

EVMN Income Statement

People Also Watch

5.36
PLYX
-3.25%
7.24
ANL
-2.23%
1.42
OBAI
-0.70%
0.78
VHUB
-1.25%
7.84
NPT
+6.52%

FAQ

What Is the Evommune (EVMN) Stock Price Today?

The Evommune stock price today is 23.59 USD.

What Stock Exchange Does Evommune Trade On?

Evommune is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Evommune?

The stock symbol for Evommune is "EVMN."

What Is the Evommune Market Cap?

As of today, Evommune market cap is 840.31M USD.

What Is Evommune's Earnings Per Share (TTM)?

The Evommune EPS (TTM) is -11.22.

When Is the Next Evommune Earnings Date?

Evommune will release its next earnings report on Jun 03, 2026.

From a Technical Analysis Perspective, Is EVMN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Evommune Stock Split?

Evommune has split 0 times.

How Many Employees Does Evommune Have?

Evommune has 48 employees.

What is the current trading status of Evommune (EVMN)?

As of Mar 23, 2026, Evommune (EVMN) is trading at a price of 23.59 USD, with a previous close of 23.33 USD. The stock has fluctuated within a day range of 22.45 USD to 24.11 USD, while its 52-week range spans from 13.89 USD to 33.20 USD.

What Is Evommune (EVMN) Price Target According to Analysts?

The average 12-month price target for Evommune is 51.00 USD, with a high estimate of 55 USD and a low estimate of 48 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +116.19% Upside potential.

What Is the EVMN After Hours Price?

EVMN's last after hours stock price is 22.69 USD, the stock has decreased by -0.64, or -2.74%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.